Literature DB >> 33882243

Comparison of prostate imaging reporting and data system v2.1 and 2 in transition and peripheral zones: evaluation of interreader agreement and diagnostic performance in detecting clinically significant prostate cancer.

Yasuyo Urase1, Yoshiko Ueno1, Tsutomu Tamada2, Keitaro Sofue1, Satoru Takahashi1,3, Nobuyuki Hinata4, Kenichi Harada4, Masato Fujisawa4, Takamichi Murakami1.   

Abstract

OBJECTIVE: To evaluate the interreader agreement and diagnostic performance of the Prostate Imaging Reporting and Data System (PI-RADS) v. 2.1, in comparison with v. 2.
METHODS: Institutional review board approval was obtained for this retrospective study. 77 consecutive patients who underwent a prostate multiparametric magnetic resonance imaging at 3.0 T before radical prostatectomy were included. Four radiologists (two experienced uroradiologists and two inexperienced radiologists) independently scored eight regions [six peripheral zones (PZ) and two transition zones (TZ)] using v. 2.1 and v. 2. Interreader agreement was assessed using κ statistics. To evaluate diagnostic performance for clinically significant prostate cancer (csPC), area under the curve (AUC) was estimated.
RESULTS: 228 regions were pathologically diagnosed as positive for csPC. With a cut-off ≥3, the agreement among all readers was better with v. 2.1 than v. 2 in TZ, PZ, or both zones combined (κ-value: TZ, 0.509 vs 0.414; PZ, 0.686 vs 0.568; both zones combined, 0.644 vs 0.531). With a cut-off ≥4, the agreement among all readers was also better with v. 2.1 than v. 2 in the PZ or both zones combined (κ-value: PZ, 0.761 vs 0.701; both zones combined, 0.756 vs 0.709). For all readers, AUC with v. 2.1 was higher than with v. 2 (TZ, 0.826-0.907 vs 0.788-0.856; PZ, 0.857-0.919 vs 0.853-0.902).
CONCLUSION: Our study suggests that the PI-RADS v. 2.1 could improve the interreader agreement and might contribute to improved diagnostic performance compared with v. 2. ADVANCES IN KNOWLEDGE: PI-RADS v. 2.1 has a potential to improve interreader variability and diagnostic performance among radiologists with different levels of expertise.

Entities:  

Mesh:

Year:  2021        PMID: 33882243      PMCID: PMC8978254          DOI: 10.1259/bjr.20201434

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  25 in total

1.  Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis.

Authors:  Yoshiko Ueno; Satoru Takahashi; Kazuhiro Kitajima; Tokunori Kimura; Ikuo Aoki; Fumi Kawakami; Hideaki Miyake; Yoshiharu Ohno; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2013-07-25       Impact factor: 5.315

2.  Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI.

Authors:  Andrew B Rosenkrantz; Ruth P Lim; Mershad Haghighi; Molly B Somberg; James S Babb; Samir S Taneja
Journal:  AJR Am J Roentgenol       Date:  2013-10       Impact factor: 3.959

3.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

4.  Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI.

Authors:  Yoshiko Ueno; Kazuhiro Kitajima; Kazuro Sugimura; Fumi Kawakami; Hideaki Miyake; Makoto Obara; Satoru Takahashi
Journal:  J Magn Reson Imaging       Date:  2013-01-04       Impact factor: 4.813

5.  Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.

Authors:  Matthew D Greer; Joanna H Shih; Nathan Lay; Tristan Barrett; Leonardo Kayat Bittencourt; Samuel Borofsky; Ismail M Kabakus; Yan Mee Law; Jamie Marko; Haytham Shebel; Francesca V Mertan; Maria J Merino; Bradford J Wood; Peter A Pinto; Ronald M Summers; Peter L Choyke; Baris Turkbey
Journal:  Radiology       Date:  2017-07-19       Impact factor: 11.105

6.  Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?

Authors:  Ely R Felker; Steven S Raman; Daniel J Margolis; David S K Lu; Nicholas Shaheen; Shyam Natarajan; Devi Sharma; Jiaoti Huang; Fred Dorey; Leonard S Marks
Journal:  AJR Am J Roentgenol       Date:  2017-08-31       Impact factor: 3.959

7.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

8.  Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales.

Authors:  Andrew B Rosenkrantz; Sooah Kim; Ruth P Lim; Nicole Hindman; Fang-Ming Deng; James S Babb; Samir S Taneja
Journal:  Radiology       Date:  2013-06-20       Impact factor: 11.105

9.  Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer.

Authors:  Janice N Thai; Harish A Narayanan; Arvin K George; M Minhaj Siddiqui; Parita Shah; Francesca V Mertan; Maria J Merino; Peter A Pinto; Peter L Choyke; Bradford J Wood; Baris Turkbey
Journal:  Radiology       Date:  2018-05-22       Impact factor: 29.146

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more
  3 in total

1.  Innovations in prostate cancer: introductory editorial.

Authors:  Jurgen J Fütterer; Chan Kyo Kim; Daniel J Margolis
Journal:  Br J Radiol       Date:  2022-03       Impact factor: 3.039

Review 2.  Diffusion and quantification of diffusion of prostate cancer.

Authors:  Yoshiko Ueno; Tsutomu Tamada; Keitaro Sofue; Takamichi Murakami
Journal:  Br J Radiol       Date:  2021-09-19       Impact factor: 3.039

3.  Inter-reader agreement of the prostate imaging reporting and data system version v2.1 for detection of prostate cancer: A systematic review and meta-analysis.

Authors:  Jing Wen; Yugang Ji; Jing Han; Xiaocui Shen; Yi Qiu
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.